Growth hormone-releasing hormone receptor signaling in experimental ocular inflammation and neuroprotection
Both inflammation and anti-inflammation are involved in the protection of retinal cells. Antagonists of the hypothalamic growth hormone-releasing hormone receptor (GHRHR) have been shown to possess potent anti-inflammatory properties in experimental disease models of various organs, some with system...
Main Authors: | Ling-Ping Cen, Tsz Kin Ng, Wai Kit Chu, Chi Pui Pang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2022;volume=17;issue=12;spage=2643;epage=2648;aulast=Cen |
Similar Items
-
Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders
by: Min Xia, et al.
Published: (2021-05-01) -
Luteinizing hormone-releasing hormone receptor agonists and antagonists in prostate cancer: effects on long-term survival and combined therapy with next-generation hormonal agents
by: Jinge Zhao, et al.
Published: (2024-11-01) -
Growth Hormone-Releasing Hormone in Lung Physiology and Pulmonary Disease
by: Chongxu Zhang, et al.
Published: (2020-10-01) -
Safety, Pharmacokinetic and Pharmacodynamic Evaluation of Teverelix for the Treatment of Hormone-Sensitive Advanced Prostate Cancer: Phase 2 Loading-Dose-Finding Studies
by: Carol M. MacLean, et al.
Published: (2023-03-01) -
Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study
by: Batool Hosein Rashidi, et al.
Published: (2019-03-01)